Multi-domain Intervention Program for Post-stroke Bone Health in Older Adults (BOUNCE)

NCT ID: NCT05939531

Last Updated: 2024-01-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

70 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-03-01

Study Completion Date

2025-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this feasibility randomized controlled trial is to assess the feasibility and compare the changes in bone mineral density before and after the intervention in post-stroke older adults. The main question\[s\] it aims to answer are:

* What are the baseline sociodemographic and bone health characteristics of post-stroke older adults in this study?
* Is it feasible to undertake a larger RCT to assess the effectiveness and implementation of BOUNCE program?
* Is there a difference in bone loss between groups?
* Is there a difference in bone turnover markers at baseline and at six months?
* Is there a difference in the incidence of falls and fragility fractures between groups?
* How receptive are post-stroke patients/carers to the use of food/exercise diary?
* What are the perceived motivators and barriers to implementation of BOUNCE program within real clinical settings among healthcare professionals, participants and carers?
* What is the experience of healthcare professionals, participants and carers undergoing BOUNCE program?

Participants will be divided into two groups:

1. Standard care
2. Intervention group (BOUNCE Program) Researchers will compare both groups to see any changes in the bone mineral density and bone turnover markers before and after the intervention.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Stroke causes secondary osteoporosis, falls and fractures. The 2020 Malaysian Stroke Guideline recommends fall and fracture risk assessment in all older stroke patients, but it does not make a firm recommendation on the interventions to address post-stroke bone loss. Stroke increased the risk of fall by 1.5 times compared to the normal population and quadrupled the risk of fracture. Hip fractures will increase the cost for treatment, hospitalization, operation and complicate the rehabilitation process from the stroke itself.

Hence, our study aims to develop and assess the feasibility of a multi-domain intervention (BOUNCE program) for bone health among older adults with acute stroke. A multi-domain non-pharmacological intervention is proposed due to the complex nature of bone loss in older post-stroke patients such as low serum Vitamin D, sarcopenia, frailty, comorbidity, ageing and hemiparesis. Therefore, this study is designed through the 2021 MRC Framework of Developing and Evaluating Complex Intervention and is divided into 3 phases. The first phase is a systematic review to identify evidence on non-pharmacological interventions for post-stroke bone health. Phase 2 is the development and validation of a novel multi-domain intervention protocol for BOUNCE program through an expert consensus development conference. The final phase will be a feasibility trial of BOUNCE program, which is further divided into two components. The first component is a randomized, controlled, single-blinded feasibility trial (RCT) of 6-months intervention (BOUNCE program) versus standard care, which primarily assesses bone loss through bone mineral density and bone turnover markers. The second component is a qualitative analysis through Focused Group Discussions on the feasibility of BOUNCE program among healthcare professionals, patients and carers. The outcome of this study will inform the next step of evaluation, which is a future full RCT to assess the effectiveness and economic studies before it can be implemented widely.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Bone Loss Stroke Geriatrics

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Standard Care

Standard post-stroke care

Group Type ACTIVE_COMPARATOR

Standard Care

Intervention Type BEHAVIORAL

Standard post-stroke care

Intervention

BOUNCE Program

Group Type EXPERIMENTAL

BOUNCE Program

Intervention Type BEHAVIORAL

Intervention arm: Bone-building exercises will be incorporated into the standard post-stroke exercises, as well as Nutritional intervention consisting of individualized diet plan based on calorie requirement, high-quality protein intake, vitamin D, Calcium and micronutrients with a one-to-one virtual session.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

BOUNCE Program

Intervention arm: Bone-building exercises will be incorporated into the standard post-stroke exercises, as well as Nutritional intervention consisting of individualized diet plan based on calorie requirement, high-quality protein intake, vitamin D, Calcium and micronutrients with a one-to-one virtual session.

Intervention Type BEHAVIORAL

Standard Care

Standard post-stroke care

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Aged 50 years old and older
* Neurologist diagnosed acute stroke within 90 days
* Has baseline biochemical test upon admission to the ward
* Able to undergo DXA scan
* Modified Rankin Score of 2 to 3
* Able to walk with or without aids

Exclusion Criteria

* Known underlying malignancy
* Known major depression or severe psychological illness
* Known chronic kidney disease stage 3b (eGFR \<45ml/min/1.73m2) or more
* Taken oral glucocorticoids therapy for at least three months
* Presence of cognitive impairment (ECAQ \<7)
* Presence of coronary artery syndrome or congestive cardiac failure
* Presence of an uncontrolled respiratory condition
* Underlying malabsorption syndrome
* Underlying conditions other than stroke that impairs mobility (eg Severe Osteoarthritis, Parkinson's Disease, Multiple sclerosis)
* Known osteoporosis or fragility fracture
* Serum phosphate or calcium abnormalities
* Discharge to a nursing home or rehabilitation centre
* Already a participant in another trial/study
Minimum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ministry of Higher Education, Malaysia

OTHER

Sponsor Role collaborator

Hospital Pengajar Universiti Putra Malaysia

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Sazlina Shariff-Ghazali, PhD

Role: STUDY_CHAIR

Universiti Putra Malaysia

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hospital Sultan Abdul Aziz Shah

Serdang, Selangor, Malaysia

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Malaysia

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Hakimah Mohammad Sallehuddin, MBBS

Role: CONTACT

+60397692893 ext. 2568

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Hakimah Mohammad Sallehuddin, MBBS

Role: primary

+60397692893 ext. 2568

Sazlina Shariff-Ghazali, PhD

Role: backup

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

JKEUPM-2022-923

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Osteoporosis After Stroke
NCT07059468 NOT_YET_RECRUITING
SB: Promoting Bone Health in Women
NCT06843486 COMPLETED PHASE1/PHASE2